Steven Kazmierski has joined Brownstein Hyatt Farber Schreck’s Denver office as a shareholder in the Intellectual Property Department.
Airina Rodrigues, co-chair of the firm’s IP Department, said Kazmierski’s “postdoctoral experience in cell and molecular biology gives him a unique ability to help clients working at the forefront of life sciences and biotechnology and guide them through regulatory and policy challenges.”
As a registered patent attorney, Kazmierski represents inventors, entrepreneurs, scientists, in-house counsel and technology transfer managers. His work includes preparing freedom-to-operate, infringement, validity and patentability opinions and performing intellectual property due diligence. He also manages patent portfolios, counsels clients on strategy, and prepares and prosecutes U.S. and international patents involving DNA and RNA technologies, protein and antibody engineering, biological and gene therapies.
Kazmierski’s patent work also extends to pharmaceuticals, drug conjugates, diagnostic assays and the underlying tools that power modern research, frequently presenting to corporate counsel, legal associations and academic conferences.
Kazmierski earned his law degree from Washington University School of Law and his doctorate and bachelor’s degrees from Florida State University.